As reported on bbc.co.uk/news. Scottish scientists have moved one step closer to conducting clinical trials of synthetic human blood thanks to the UK’s Medicines and Healthcare product Regulatory Agency (MHRA).
Having been awarded a licence by the MHRA, researchers at the Scottish National Blood Transfusion Service, Edinburgh University and Roslin Cells are able to use stem cells to manufacture blood that could eventually be tested on people.
The licence means a manufacturing facility, which will be based at the Scottish Centre for Regenerative Medicine (SCRM) can be set up to work on human cell therapy products with the aim of producing blood that will be fit for clinical trials.
The synthetic blood would be used to help help supply shortages and prevent infections being passed on through donations.